Related Experiment Video

Updated: Jun 11, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays

K Malinowsky1, C Wolff, B Ergin

  • 1Department of Pathology, Technische Universität München, Munich, Germany. katharina.malinowsky@lrz.tum.de

Journal of Cellular Physiology
|July 14, 2010
PubMed

Insights

Pathology faces new challenges with targeted cancer therapies. Reverse phase protein microarray (RPPA) analysis of formalin-fixed, paraffin-embedded (FFPE) tissues offers a precise method for quantifying therapeutic targets and diagnostic markers.

Area of Science:

  • Oncology
  • Molecular Pathology
  • Biotechnology

Background:

  • Cancer therapy is shifting from general chemotherapy/radiotherapy to targeted molecular approaches.
  • This transition requires pathology to move beyond diagnosis and staging to predicting therapeutic outcomes.
  • Detecting and quantifying specific molecular targets like HER2 is crucial for personalized cancer treatment.

Purpose of the Study:

  • To explore the utility of Reverse Phase Protein Microarray (RPPA) for analyzing signaling pathways in cancer.
  • To demonstrate the application of RPPA for quantifying therapeutic targets and diagnostic markers in formalin-fixed, paraffin-embedded (FFPE) tissues.
  • To highlight RPPA as a tool for fast, precise, and simultaneous analysis of multiple cancer-related proteins using minimal clinical material.

Main Methods:

  • Utilized Reverse Phase Protein Microarray (RPPA) technology.
  • Developed and applied methods for protein extraction from formalin-fixed, paraffin-embedded (FFPE) tissues.
  • Performed quantitative measurement of protein expression profiles.

Main Results:

  • Demonstrated the feasibility of using RPPA to analyze signaling pathways from FFPE tissues.
  • Showcased the potential of RPPA for accurate quantification of therapeutic targets.
  • Indicated RPPA's capability in quantifying important diagnostic markers relevant to cancer therapy.

Conclusions:

  • RPPA is a promising technology for quantitative protein analysis in cancer pathology.
  • Analyzing FFPE tissues with RPPA can enhance the quantification of therapeutic targets and diagnostic markers.
  • This approach supports the development of more precise and personalized cancer therapies.

More Related Videos

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

Probing High-density Functional Protein Microarrays to Detect Protein-protein Interactions08:07

Probing High-density Functional Protein Microarrays to Detect Protein-protein Interactions

Published on: August 2, 2015

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...